[GYNANDROIDS OF DRUG ORIGIN].
D000014:Abnormalities, Drug-Induced; D045930:Anabolic Agents; D000728:Androgens; D012734:Disorders of Sex Development; D004963:Estrenes; D005260:Female; D005315:Fetal Diseases; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008431:Maternal-Fetal Exchange; D008777:Methyltestosterone; D011247:Pregnancy; D011372:Progestins; D013256:Steroids; D013739:Testosterone / Q000031:analogs & derivatives; D014116:Toxicology; D014770:Virilism
C509325:19-nor-17-methyltestosterone; D045930:Anabolic Agents; D000728:Androgens; D004963:Estrenes; D011372:Progestins; D013256:Steroids; D013739:Testosterone; C073330:methylestrenolone; D008777:Methyltestosterone
ABNORMALITIES, DRUG-INDUCED; ANABOLIC STEROIDS; ANDROGENS; FETAL DISEASES; HERMAPHRODITISM; INFANT, NEWBORN; MATERNAL-FETAL EXCHANGE; METHYLTESTOSTERONE; NORMETHANDROLONE; PREGNANCY; PROGESTATIONAL HORMONES; SEX DIFFERENTIATION DISORDERS; TOXICOLOGIC REPORT; VIRILISM
GINANDROIDES DE ORIGEN MEDICAMENTOSO.